Effects of continued androgen-deprivation therapy and other prognostic factors on response and survival in phase II chemotherapy trials for hormone-refractory prostate cancer: a Southwest Oncology Group report.
Year: 1994
Type: article
Source: Journal of Clinical Oncology
Authors: M Hussain, M Wolf, E Marshall, E D Crawford, M Eisenberger
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W1776913920
